Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

WoS shares slide amid US tariff uncertainty

(Sharecast News) - Watches of Switzerland shares fell sharply as the luxury brands seller reported a fall in annual profits and warned products exported to the US would be hit by tariff increases. Pre-tax profit for the year to April 27 fell 18% to £76m, while revenue grew 7% to £1.65bn. WoS said it was still too early to comment on the potential impact of any US tariff changes. Shares in the firm were down 6% in early London trade.

The company, which sells luxury watches such as Rolex and Audemars Piguet said the 10% duty on goods from Switzerland had led to some brand partners raising prices in the US by mid-single digits.

"The outcome of US tariff developments remains uncertain. We are in regular dialogue with our brand partners, but it is too early further changes. We will provide a further update as to the potential impact on FY26 guidance once the situation becomes clearer," the company said on Thursday.

US President Donald Trump originally hammered Switzerland with a 31% levy, sending shares in the firm crashing by a fifth. A 90-day pause on implementing the duty ends on July 9 as countries scramble to appease the authoritarian American leader.

Adjusted earnings before interest, tax depreciation and amortization rose 8% to £192m, while operating profit fell 5% to £114m.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.